In this book, you will find a compilation of publications from experts in the field of lung cancer screening from across the globe. The authors discuss the current status of lung cancer screening throughout the world, the use of radiomics, artificial intelligence and biomarkers in lung cancer screening, smoking cessation and psychologic effects associated with screening, and the challenges of lung cancer screening. This will be a valuable resource for all of those involved in lung cancer screening. The last decade saw the publication of the first trials demonstrating the benefit of LDCT screening in the reduction of lung cancer mortality and the subsequent implementation of lung cancer screening programs across the globe. In the next decade, we must focus on the safe and effective expansion of screening, decreasing disparities while optimizing risk/ benefit ratio. This book is a timely start to this process.